While its effectiveness is still being researched, clinical therapists across the country and here at Bryan Medical say it’s mostly beneficial for treatment-resistant depression patients.

Ketamine is rarely lethal, but an overdose can cause unconsciousness and dangerously slowed breathing, according to the Drug ...

More awareness, research, and treatments are needed The rise in non-prescribed use of ketamine across the UK in recent years ...

The rise in non-prescribed ketamine use across the UK in recent years is a cause for concern, say doctors in The BMJ.

The rise in non-prescribed ketamine use across the UK in recent years is a cause for concern, say doctors in The BMJ today.

It is now approved for adults with treatment-resistant depression (TRD) who have cycled through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster ...

(NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, ...

Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD ... behind Spravato – an intranasal formulation of esketamine – with the release of top-line data from a head ...

He completed a fellowship in Interventional Neuropsychiatry and Neuromodulation at Massachusetts General Hospital, bringing ...

Melancholic depression, also called melancholia, is a serious type of depression. Researchers think this type of depression mainly affects your central nervous system. About 25%-30% of people ...